Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Handle millions of rows by loading queries into Power Pivot, building relationships, and creating measures for fast variance ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

If you are wondering whether Occidental Petroleum is attractively priced or not, this article walks through the key numbers ...

Darryn Peterson dropped a career-high 32 points in his return to the starting lineup after a lingering hamstring injury on ...